Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.450
-0.040 (-2.68%)
Jun 1, 2026, 9:40 AM EDT - Market open
PACB Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 160.03 | 160.01 | 154.01 | 200.52 | 128.3 | 130.51 | |
Revenue Growth (YoY) | 5.04% | 3.89% | -23.19% | 56.29% | -1.69% | 65.43% |
Cost of Revenue | 99.31 | 109.33 | 107.34 | 145.76 | 78.54 | 71.35 |
Gross Profit | 60.72 | 50.67 | 46.68 | 54.76 | 49.77 | 59.17 |
Selling, General & Admin | 132.48 | 141.49 | 175.02 | 169.82 | 160.85 | 124.12 |
Depreciation & Amortization Expenses | 4.06 | 369.44 | 27.4 | 8.14 | 0.73 | 0.31 |
Research & Development | 87.86 | 97.31 | 134.92 | 187.17 | 193 | 112.9 |
Other Operating Expenses | 61.2 | -3.7 | 183.65 | 24.1 | 2.38 | 32.27 |
Total Operating Expenses | 285.6 | 604.54 | 520.99 | 389.23 | 356.96 | 269.6 |
Operating Income | -133.28 | -553.86 | -474.31 | -334.47 | -307.2 | -210.44 |
Interest Expense | -6.96 | -6.95 | -13.41 | -14.34 | -14.69 | -12.53 |
Other Non-Operating Income (Expense) | 12.47 | 14.76 | 178.19 | 30.65 | 7.64 | -51.91 |
Total Non-Operating Income (Expense) | 5.51 | 7.8 | 164.78 | 16.31 | -7.05 | -64.44 |
Pretax Income | -127.77 | -546.06 | -309.54 | -318.16 | -314.25 | -274.87 |
Provision for Income Taxes | 0.8 | 0.32 | 0.32 | -11.42 | - | -93.65 |
Net Income | -128.58 | -546.38 | -309.85 | -306.74 | -314.25 | -181.22 |
Net Income to Common | -128.58 | -546.38 | -309.85 | -306.74 | -314.25 | -181.22 |
Shares Outstanding (Basic) | 302 | 300 | 274 | 254 | 225 | 204 |
Shares Outstanding (Diluted) | 302 | 300 | 288 | 254 | 225 | 204 |
Shares Change (YoY) | 5.19% | 4.02% | 13.70% | 12.95% | 10.00% | 16.67% |
EPS (Basic) | -0.43 | -1.82 | -1.13 | -1.21 | -1.40 | -0.89 |
EPS (Diluted) | -0.43 | -1.82 | -1.59 | -1.21 | -1.40 | -0.89 |
Shares Outstanding | 310.49 | 301.96 | 294.42 | 267.74 | 226.51 | 220.98 |
Free Cash Flow | -116.21 | -113.92 | -212.25 | -268.02 | -279.96 | -117.11 |
Free Cash Flow Per Share | -0.38 | -0.38 | -0.74 | -1.06 | -1.25 | -0.57 |
Gross Margin | 37.95% | 31.67% | 30.31% | 27.31% | 38.79% | 45.33% |
Operating Margin | -83.29% | -346.15% | -307.97% | -166.80% | -239.43% | -161.24% |
Profit Margin | -80.34% | -341.47% | -201.18% | -152.97% | -244.93% | -138.85% |
FCF Margin | -72.62% | -71.20% | -137.81% | -133.66% | -218.20% | -89.73% |
EBITDA | -119.15 | -171.43 | -433.13 | -314.74 | -296.8 | -202.86 |
EBITDA Margin | -74.45% | -107.14% | -281.23% | -156.96% | -231.33% | -155.43% |
EBIT | -133.28 | -553.86 | -474.31 | -334.47 | -307.2 | -210.44 |
EBIT Margin | -83.29% | -346.15% | -307.97% | -166.80% | -239.43% | -161.24% |
Effective Tax Rate | -0.63% | -0.06% | -0.10% | 3.59% | 0.00% | 34.07% |